Decreased plasma adiponectin is associated with impaired left ventricular longitudinal systolic function in hypertensive patients: a two-dimensional speckle tracking study

Clin Exp Hypertens. 2014;36(1):46-51. doi: 10.3109/10641963.2013.783053. Epub 2013 Jun 17.

Abstract

The influence of plasma adiponectin levels on myocardial contractile function has not been fully examined. We aimed to investigate the relationship between three-directional systolic function and plasma adiponectin levels in asymptomatic hypertensive patients using two- dimensional speckle-tracking echocardiography. The study population consisted of 78 patients with hypertension and 40 healthy controls. Longitudinal strain was significantly reduced in all patients, including those without LV hypertrophy (p=0.009). In multiple-regression analysis, plasma adiponectin levels (β=-0.273, p=0.008) and LV mass index (β=0.458, p<0.001) independently correlated with LV longitudinal strain. Decreased plasma adiponectin concentrations were associated with the progression of LV hypertrophy with impaired LV longitudinal systolic function.

MeSH terms

  • Adiponectin / blood*
  • Adiponectin / deficiency
  • Adult
  • Case-Control Studies
  • Echocardiography / methods
  • Female
  • Humans
  • Hypertension / blood*
  • Hypertension / complications
  • Hypertension / diagnostic imaging*
  • Hypertrophy, Left Ventricular / blood
  • Hypertrophy, Left Ventricular / diagnostic imaging
  • Hypertrophy, Left Ventricular / etiology
  • Male
  • Middle Aged
  • Myocardial Contraction / physiology
  • Systole / physiology
  • Ventricular Dysfunction, Left / blood*
  • Ventricular Dysfunction, Left / diagnostic imaging*
  • Ventricular Dysfunction, Left / etiology

Substances

  • ADIPOQ protein, human
  • Adiponectin